Cumberland Pharmaceuticals Inc.

3.12+0.1100+3.65%Vol 145.34K1Y Perf -20.85%
Apr 13th, 2021 16:00 DELAYED
BID3.08 ASK3.12
Open3.05 Previous Close3.01
Pre-Market- After-Market3.17
 - -  0.05 1.60%
Target Price
8.50 
Analyst Rating
Strong Buy 1.00
Potential %
172.44 
Finscreener Ranking
★★★★★     61.66
Insiders Trans % 3/6/12 mo.
-/-/100 
Value Ranking
★★★+     54.30
Insiders Value % 3/6/12 mo.
-/-/100 
Growth Ranking
★★+     51.66
Insiders Shares Cnt. % 3/6/12 mo.
-/-/100 
Income Ranking
 —    -
Market Cap46.55M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
25.00 
Earnings Date
19th May 2021

Today's Price Range

3.003.20

52W Range

2.774.17

5 Year PE Ratio Range

-83.90140.70

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.32%
1 Month
-8.77%
3 Months
-4.00%
6 Months
1.63%
1 Year
-20.85%
3 Years
-51.55%
5 Years
-32.90%
10 Years
-39.77%

TickerPriceChg.Chg.%
CPIX3.120.11003.65
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Financial StrengthValueIndustryS&P 500US Markets
1.40
1.90
0.25
0.41
-23.90
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
76.90
-16.80
-4.20
-15.00
-7.94
RevenueValueIndustryS&P 500US Markets
29.11M
1.95
-0.52
5.22
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.03-0.0166.67
Q03 2020-0.090.00100.00
Q02 20200.010.07600.00
Q01 20200.00-0.01-
Q04 2019-0.010.07800.00
Q03 20190.09-0.02-122.22
Q02 20190.050.0740.00
Q01 2019-0.130.09169.23
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.090.00-
6/2021 QR-0.0150.00Positive
12/2021 FY-0.080.00-
12/2022 FY-0.03--
Next Report Date19th May 2021
Estimated EPS Next Report-0.09
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume145.34K
Shares Outstanding14.92M
Trades Count670
Dollar Volume198.52K
Avg. Volume65.06K
Avg. Weekly Volume49.31K
Avg. Monthly Volume29.44K
Avg. Quarterly Volume70.85K

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) stock closed at 3.12 per share at the end of the most recent trading day (a 3.65% change compared to the prior day closing price) with a volume of 146.74K shares and market capitalization of 46.55M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 94 people. Cumberland Pharmaceuticals Inc. CEO is A. J. Kazimi.

The one-year performance of Cumberland Pharmaceuticals Inc. stock is -20.85%, while year-to-date (YTD) performance is 5.76%. CPIX stock has a five-year performance of -32.9%. Its 52-week range is between 2.77 and 4.17, which gives CPIX stock a 52-week price range ratio of 25.00%

Cumberland Pharmaceuticals Inc. currently has a PE ratio of -15.00, a price-to-book (PB) ratio of 1.05, a price-to-sale (PS) ratio of 1.54, a price to cashflow ratio of 9.20, a PEG ratio of 2.32, a ROA of -3.18%, a ROC of -4.67% and a ROE of -6.51%. The company’s profit margin is -7.94%, its EBITDA margin is -4.20%, and its revenue ttm is $29.11 Million , which makes it $1.95 revenue per share.

Of the last four earnings reports from Cumberland Pharmaceuticals Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.09 for the next earnings report. Cumberland Pharmaceuticals Inc.’s next earnings report date is 19th May 2021.

The consensus rating of Wall Street analysts for Cumberland Pharmaceuticals Inc. is Strong Buy (1), with a target price of $8.5, which is +172.44% compared to the current price. The earnings rating for Cumberland Pharmaceuticals Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cumberland Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cumberland Pharmaceuticals Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.89, ATR14 : 0.18, CCI20 : -45.33, Chaikin Money Flow : 0.02, MACD : -0.04, Money Flow Index : 55.03, ROC : 0.32, RSI : 46.84, STOCH (14,3) : 38.71, STOCH RSI : 0.54, UO : 46.57, Williams %R : -61.29), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cumberland Pharmaceuticals Inc. in the last 12-months were: Joseph C. Galante (Buy at a value of $36 627)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
0
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0
Hold
0 (0.00 %)
0 (0.00 %)
0
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0
Strong Sell
0 (0.00 %)
0 (0.00 %)
0
Summary RatingStrong Buy
1.00
Strong Buy
1.00
-

Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It focuses on the acquisition, development, and commercialization of branded prescription products. The company provides prescription products to hospital acute care and gastroenterology to address unmet or poorly met medical needs. Its product brands include Acetadote, Caldolor, Kristalose, Omeclamox- Pak, Vaprisol and Ethyol.

CEO: A. J. Kazimi

Telephone: +1 615 255-0068

Address: 2525 West End Avenue, Nashville 37203, TN, US

Number of employees: 94

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

45%55%

Bearish Bullish

47%53%

News

Stocktwits